PGS/PGT-A is a pre-implantation process conducted with the aim of identifying chromosome number abnormality by excisional biopsy of the trophoblast of the embryo with a small number of samples.
According to international statistics, the embryo abnormality rate of couples at the age of 38 or older is 50-60%. PGT-A screening can efficiently identify chromosomally abnormal blastocysts and forestall the possibility of Down syndrome, Turner syndrome, and other genetic diseases.
service items
Main Service/
Main Service
/genetic diagnosis/
Genetic Diagnosis
PGT-A / PGS
PGS/PGT-A
PGS/PGT-A
/Suitable/
The subject of PGS/PGT-A
Infertile couple
Recurrent pregnancy loss
Multiple embryo implantation failures (may be attributable to aneuploid)
Advanced maternal age
Family members have been diagnosed with chromosomal abnormalities (e.g., balanced reciprocal translocation)
Other issues for which IVF may be required for conception.
/examination/
Diseases that can be identified
Unpaired chromosomes: Down syndrome, Prader-Willi syndrome, Cri du chat syndrome, Turner syndrome, Klinefelter's syndrome, Edwards syndrome, Patau syndrome, etc.
/Treatment process/
Detection process
01
/
Step01
Physician consultation
Step02
Egg retrieval
Step03
Embryo fertilization
Step04
Blastocyst stage embryo biopsy
Step05
Sample screening
Step06
Report
about 2 weeks
Conclusion
In our laboratory, we rigorously evaluate blastocysts graded BC or higher, ensuring they meet the criteria set by our experienced embryologists. These blastocysts undergo biopsy procedures designed not to harm their integrity, allowing us to perform PGT-A testing for chromosomal abnormalities. By selecting chromosomally normal blastocysts for transfer, we significantly enhance implantation success rates.
